AVXL (Anavex Life Sciences Corp.) Net Profit

Corporate emblem and logo of anavex.com (AVXL)

Anavex Life Sciences (AVXL) delegates medical testing to external contractors, which optimizes expenses and increases capital flexibility. Strategic alliances with global funds accelerate the launch of new drugs. This price chart reflects profits at the level of -0.01. Breakthroughs in dementia therapy are achieved through close cooperation with leading neurological centers and joint research.

AVXL - Anavex Corp Net Profit over the range 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for Anavex Life Sciences Corp. (AVXL)

- stock value and consensus price forecast:
Market Price Anavex Life Sciences Corp|AVXL - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Anavex Life Sciences Corp|AVXL - Total Company Value
- book capitalization data:
Equity per Share Anavex Life Sciences|AVXL - Book Capitalization|Market Capitalization to Book Value Ratio anavex.com|AVXL - Cumulative Company Assets
- debt and liquidity details:
Debt to Equity Anavex Life Sciences|AVXL - Long-Term Debt to Capital|Current Liabilities to Capital Anavex|AVXL - Company Total Debt|Debt to Book Value Ratio Anavex Life Sciences Corp|AVXL - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Anavex Life Sciences|Quick Liquidity anavex.com
- earnings and market ratios statistics:
AVXL - Net Profit
Summary company analysis:Anavex Life Sciences Corp
Finished products of Anavex Life Sciences

The development of innovative drugs for Alzheimer's and Parkinson's diseases directly impacts the final financial result of Anavex Life Sciences (AVXL), available on GURU.Markets. This indicator calculates actual net profit in real time, eliminating the time lag associated with quarterly reporting. It measures real cash flow, stripped of accounting assumptions. The curve's dynamics reveal hidden cash gaps and debt loads. Analyzing this metric allows investors to avoid overleveraged biopharmaceutical assets.

Key competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Profit regencellbioscience.com|Company Net Income Axsome Therapeutics, Inc. (AXSM)|ACADIA Pharma - Company Profit|Net Profit XENE (Xenon Pharmaceuticals Inc)|Net Profit Viking Therapeutics Corp VKTX|SUPN: Net Income|CPRX: Company Net Income|DNLI: Net Profit|Company Net Income Harmony Biosciences Inc (HRMY)|Net Income BHVN|Company Profit AMLX (Amylyx Corp)|Net Income TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Final Profit|Company Net Income CeriBell CBLL|Prothena Corp - Company Net Income|Alector Therapeutics - Net Profit|Net Financial Result Annexon Biosciences Inc. ANNX|OMER: Net Profit|Profit After Tax NGNE (neurogene.com)|ACIU (AC Immune SA) - Net Profit|Company Net Income Voyager Therapeutics Inc VYGR|Net Income NMRA (Neumora Therapeutics Inc)|SCLX (Scilex Holding Company, Inc.) - Final Profit|Company Net Income Tevogen Bio Holdings TVGN|Net Financial Result Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Net Profit|Inhibikase Therapeutics Inc (IKT) - Net Income|SAVA: Net Profit|ASRT - Net Financial Result|COYA (Coya Therapeutics Inc) - Net Profit|Company Net Income VistaGen Therapeutics Inc VTGN|Company Net Income Ovid Therapeutics Inc. (OVID)|Acumen Pharmaceuticals Inc. - Company Profit|Net Profit CRVO (CervoMed Inc)|ATHE - Net Income|Clene Nanomedicine - Net Profit|Company Net Income PepGen Inc.|Jupiter Neurosciences Inc (JUNS) - Company Net Income|RLMD - Net Financial Result|ANVS (Annovis Bio Corp) - Net Profit|Net Profit Grace Tx|Net Income AIFF (Firefly Neuroscience, Inc)|Company Net Income KLTO (anewmeds.com)|NeuroSense Therapeutics Ltd. - Net Income|RVPH: Company Profit|MTVA - Company Net Income|NRXS: Company Net Income|heliusmedical.com (HSDT) - Company Net Income|Company Profit PASG|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|Company Net Income Minerva Neurosciences Inc NERV|Net Income ATHA (Athira)|Net Profit Addex (ADXN)|Company Net Income Alzamend Neuro ALZN|Final Profit CYCN|PTIX - Company Net Income|Company Net Income Pasithea Therapeutics|CRGT: Net Profit|Avenue Therapeutics Inc (ATXI) - Net Profit|Company Net Income Brainstorm Cell|Company Profit CARA (caratherapeutics.com)|Net Profit CHRO|Net Profit eliemtx.com (ELYM)|Intra-Cellular Therapies, Inc. - Net Income|Longboard - Company Net Income|Marinus Pharmaceuticals - Net Profit|Company Net Income nkgenbiotech.com|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net Income|Company Profit SAGE|Net Income SNPX|TRVN: Final Profit|Company Net Income Vigil Neuroscience (VIGL)|Company Net Income WENA (Anew Medical Inc.)|Net Profit CERE (Cerevel Therapeutics, Inc.)